Event Brief
Moderna begins Phase 1 trial for Bundibugyo Ebola vaccine
Filed: Aug 05, 2026 at 9:10 AM ET
Summary: Moderna vaccinated first volunteers in a Phase 1 trial for a Bundibugyo Ebola mRNA vaccine in Canada.
WHO: Moderna
WHAT: Vaccinated first participants in a Phase 1 trial of an mRNA Bundibugyo Ebola vaccine candidate
WHEN: Aug 05, 2026 at 8:31 AM ET
WHERE: Canada
WHY: To evaluate safety, tolerance, and immune response for the Bundibugyo strain of Ebola virus disease, for which there is currently no vaccine
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
🔍 Sources (8) 🔒
Pakistan and US hold fourth counter-terrorism dialogue
Pakistan
Aug 05, 2026 at 9:10 AM ET
🔒
China announces countermeasures after US trade sanctions
Asia-Pacific
Aug 05, 2026 at 9:08 AM ET
🔒
South Korea police raid Starbucks HQ over 'Tank Day' backlash
Starbucks
Aug 05, 2026 at 9:08 AM ET
🔒
Tinubu approves up to 80% pay rise for soldiers
Africa
Aug 05, 2026 at 9:08 AM ET
🔒
